Female infertility. Female infertility ,unspecified
Conditions
Interventions
Intervention 1: In interventional group delay Gn RH antagonist protocol for controlled ovarian hyper stimulation is used. All patients are received estrogen tablet 2 milligram daily starting in mid lu
Treatment - Drugs
In interventional group delay Gn RH antagonist protocol for controlled ovarian hyper stimulation is used. All patients are received estrogen tablet 2 milligram daily starting in mid luteal previous cy
In control group, microdose flare Gn RH agonist protocol for controlled ovarian hyperstimulation is used.On the second day of menstrual cycle Buserlin acetate (Cinnafact, Cinnagen) 50 micro gram twice
Sponsors
Vice chancellor for research, Shahid Sadoughi University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 42 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: infertile women between 18 to 42 years old with =8 antral follicle count in bilateral ovaries; and or patients with basal follicle stimulating hormone (FSH) = 9 milli unit per milliliter; and or patients with a history of cancelled invitro fertilization(IVF) cycle =3 dominant follicles; and or =500 pico mole per liter estradiol (E2) levels at human chorionic gonadotropin( hCG) administration day. Exclusion criteria: patients under 18 years old or over 42 years old; patients with sever male factor
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical pregnancy. Timepoint: 28 days after transfer. Method of measurement: Vaginal sonography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of mature oocytes. Timepoint: Oocyte pucture day. Method of measurement: Number of M2 oocytes. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDR Nosrat Neghab
Yazd Research and Clinical Center for Infertility Shahid Sadoughi University of Medical Sciences
Outcome results
None listed